Omninano Pharmaceuticals
OmniNano is an IND-enabling stage therapeutics company spun out of MD Anderson Cancer Center that operates at the intersection of therapeutics, drug delivery, and nanomedicine, with a primary focus on revolutionizing treatment for hard-to-treat solid tumors. OmniNano’s patented polymeric micelle platform offers a unique competitive advantage: preferential delivery of multiple drugs to solid tumors. Our lead asset, designed specifically for pancreatic cancer, simultaneously delivers two complementary therapeutics—one targeting the stroma and the other targeting cancer cells—and addresses key limitations of current therapies.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
3
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Omninano Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Omninano Pharmaceuticals
1 distinct titles indexed · top 1 shown.
- 1co-founder, svp for translational science and operations
Sign up to unlock all 2 contacts at Omninano Pharmaceuticals
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Omninano Pharmaceuticals
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.